aTYR PHARMA INC (ATYR) Operating income 2016–2025
aTYR PHARMA INC (ATYR) annual operating income history from SEC filings — each fiscal year as reported.
-$77.6MFY2025 · since FY2016: -$57.9M → -$77.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$77.6M | -14.3% |
| FY2024 | -$67.9M | -23.7% |
| FY2023 | -$54.9M | -18.3% |
| FY2022 | -$46.4M | -36.4% |
| FY2021 | -$34.0M | -113.8% |
| FY2020 | -$15.9M | +30.8% |
| FY2019 | -$23.0M | +30.0% |
| FY2018 | -$32.8M | +30.4% |
| FY2017 | -$47.1M | +18.6% |
| FY2016 | -$57.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATYR financial trends
ATYR RevenueATYR Net incomeATYR Net marginATYR Gross profitATYR Gross marginATYR Operating marginATYR Operating cash flowATYR Free cash flowATYR Capital expendituresATYR Return on equityATYR Stock buybacksATYR Dividends paidATYR Total assetsATYR Total liabilitiesATYR Shareholders’ equityATYR overview →